UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

1. Role of HDL in reverse cholesterol transport

Atherosclerosis, 1999, Vol.146, p.S1-S1

1999

Link zum Volltext

Verfügbarkeit prüfen

Characterization of atherosclerosis in a patient with familial high-density lipoprotein deficiency

Atherosclerosis, 1994-10, Vol.110 (2), p.203-208

1994

Link zum Volltext

Verfügbarkeit prüfen

ABC transporters, atherosclerosis and inflammation

Atherosclerosis, 2010-08, Vol.211 (2), p.361-370

2010

Link zum Volltext

Verfügbarkeit prüfen

Dietary inflammatory index and cardiometabolic risk in US adults

Atherosclerosis, 2018-09, Vol.276, p.23-27

2018

Link zum Volltext

Verfügbarkeit prüfen

Plasma levels of the oxyphytosterol 7α-hydroxycampesterol are associated with cardiovascular events

Atherosclerosis, 2018-12, Vol.279, p.17-22

2018

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein E isoforms differentially affect LCAT-dependent cholesterol esterification

Atherosclerosis, 2023-10, Vol.382, p.117266-117266, Article 117266

2023

Link zum Volltext

Verfügbarkeit prüfen

Family history of coronary heart disease and markers of subclinical cardiovascular disease: Where do we stand?

Atherosclerosis, 2013-06, Vol.228 (2), p.285-294

2013

Link zum Volltext

Verfügbarkeit prüfen

Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides

Atherosclerosis, 2014-10, Vol.236 (2), p.244-250

2014

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans

Atherosclerosis, 2013-10, Vol.230 (2), p.322-329

2013

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein A-I mimetic peptide reverses impaired arterial healing after injury by reducing oxidative stress

Atherosclerosis, 2015-08, Vol.241 (2), p.709-715

2015

Link zum Volltext

Verfügbarkeit prüfen

RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease

Atherosclerosis, 2016-04, Vol.247, p.48-57

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: A phase 3 study

Atherosclerosis, 2009-05, Vol.204 (1), p.208-215

2009

Link zum Volltext

Verfügbarkeit prüfen

Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice

Atherosclerosis, 2005-07, Vol.181 (1), p.9-18

2005

Link zum Volltext

Verfügbarkeit prüfen

Leukocyte telomere length is associated with HDL cholesterol levels: The Bogalusa heart study

Atherosclerosis, 2009-08, Vol.205 (2), p.620-625

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects

Atherosclerosis, 2011-12, Vol.219 (2), p.761-767

2011

Link zum Volltext

Verfügbarkeit prüfen

A synonymous variant in scavenger receptor, class B, type I gene is associated with lower SR-BI protein expression and function

Atherosclerosis, 2010-05, Vol.210 (1), p.177-182

2010

Link zum Volltext

Verfügbarkeit prüfen

Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy

Atherosclerosis, 2009-08, Vol.205 (2), p.528-532

2009

Link zum Volltext

Verfügbarkeit prüfen

Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia

Atherosclerosis, 2006-08, Vol.187 (2), p.393-400

2006

Link zum Volltext

Verfügbarkeit prüfen

Population-based study of SR-BI genetic variation and lipid profile

Atherosclerosis, 2004-07, Vol.175 (1), p.159-168

2004

Link zum Volltext

Verfügbarkeit prüfen

Hypercholesterolemia is associated with visual field alterations detectable with computerized perimetry

Atherosclerosis, 2007-11, Vol.195 (1), p.e167-e171

2007

Link zum Volltext

Verfügbarkeit prüfen

Plasma triglyceride levels and body mass index values are the most important determinants of preβ-1 HDL concentrations in patients with various types of primary dyslipidemia

Atherosclerosis, 2010-02, Vol.208 (2), p.506-511

2010

Link zum Volltext

Verfügbarkeit prüfen

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

Atherosclerosis, 1993-12, Vol.104 (1), p.129-135

1993

Link zum Volltext

Verfügbarkeit prüfen

Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor

Atherosclerosis, 1997-11, Vol.135 (1), p.119-130

1997

Link zum Volltext

Verfügbarkeit prüfen

Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein

Atherosclerosis, 2000-03, Vol.149 (1), p.5-17

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAtherosclerosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

1. Role of HDL in reverse cholesterol transport

Characterization of atherosclerosis in a patient with familial high-density lipoprotein deficiency

ABC transporters, atherosclerosis and inflammation

Dietary inflammatory index and cardiometabolic risk in US adults

Plasma levels of the oxyphytosterol 7α-hydroxycampesterol are associated with cardiovascular events

Apolipoprotein E isoforms differentially affect LCAT-dependent cholesterol esterification

Family history of coronary heart disease and markers of subclinical cardiovascular disease: Where do we stand?

Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides

Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans

Apolipoprotein A-I mimetic peptide reverses impaired arterial healing after injury by reducing oxidative stress

RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease

Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: A phase 3 study

Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice

Leukocyte telomere length is associated with HDL cholesterol levels: The Bogalusa heart study

Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects

A synonymous variant in scavenger receptor, class B, type I gene is associated with lower SR-BI protein expression and function

Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy

Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia

2016 European Guidelines on cardiovascular disease prevention in clinical practice

Population-based study of SR-BI genetic variation and lipid profile

Hypercholesterolemia is associated with visual field alterations detectable with computerized perimetry

Plasma triglyceride levels and body mass index values are the most important determinants of preβ-1 HDL concentrations in patients with various types of primary dyslipidemia

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor

Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein

Aktive Filter

Suchergebnisse filtern